Hims & Hers Health to acquire Australia’s Eucalyptus for up to $1.15 billion

Hims & Hers Health said on Thursday it will acquire Australian digital health company Eucalyptus in a deal valued at up to $1.15 billion, as the U.S. telehealth platform seeks to broaden its personalized care business into new international markets.
The deal would give Hims & Hers a foothold in Australia and Japan while deepening its presence in the United Kingdom, Germany, and Canada through partnerships with established regional operators.
Eucalyptus operates several consumer-focused brands globally, including weight-loss program Juniper and men’s telehealth brand Pilot, and has served more than 775,000 customers, according to Hims & Hers.
Hims & Hers is currently facing a lawsuit from Danish drugmaker Novo Nordisk NOVO_B after a crackdown from the U.S. Food and Drug Administration forced it to abruptly withdraw its newly launched $49 copy of Novo’s blockbuster weight-loss pill Wegovy.
The deal is expected to close during the middle of calendar year 2026. About $240 million will be payable in cash upon closing of the acquisition, Hims & Hers said.